Tack endovascular system - search results
If you're not happy with the results, please do another search
First US commercial use of Tack Endovascular System (4F) in BTK arteries announced
Intact Vascular has announced the first commercial use of its Tack Endovascular System (4F) in multiple sites across the USA. Notably the first FDA-approved...
First US commercial use of Tack Endovascular System in BTK arteries announced
Intact Vascular has announced the first commercial use of its Tack Endovascular System (4F) in multiple sites across the USA. Notably the first FDA-approved...
Tack Endovascular System® reveals “impressive” six-month results below the knee
George Adams, MD (Raleigh, USA) talks to Vascular News at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the six-month data from the TOBA II...
Tack Endovascular System® reveals “impressive” six-month results below the knee
George Adams, MD (Raleigh, USA) talks to Vascular News at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the six-month data from the TOBA II...
Tack Endovascular System receives FDA approval for below-the-knee post-angioplasty dissection repair
Intact Vascular has received US Food and Drug Administration (FDA) approval for the Tack Endovascular System (4F), a novel, minimal metal implant for precision...
Intact Vascular expands Tack Endovascular System portfolio offering
Intact Vascular has announced US Food and Drug Administration (FDA) pre-market approval (PMA) for the expansion of its Tack Endovascular System (6F) portfolio. The...
Real-world use of the Tack Endovascular System published
Intact Vascular has announced the peer-reviewed publication, “Practical applications of Tack implants for infrainguinal dissection repair: A single-centre experience” currently available online, with...
With focal dissection repair, the Tack Endovascular System “returns control to the operator”
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the...
Tack Endovascular System launches in the USA, first commercial use announced
Intact Vascular has announced the first commercial use of its Tack Endovascular System in multiple sites across the USA. Recently FDA-approved for above-the-knee interventions,...
Intact Vascular’s Tack Endovascular System receives FDA approval
Intact Vascular has announced it received US Food and Drug Administration (FDA) approval for the Tack Endovascular System (6F), a purpose-built dissection repair device implanted...
Tack Endovascular System launches in the EU with first commercial use in Germany
The first commercial use of the Tack Endovascular System (Intact Vascular) has taken place in multiple hospitals within Germany. A novel therapy for dissection...
Tack Endovascular System secures US$20 million in premarket approval funding
Intact Vascular, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced that it closed a Series C financing totaling US$20 million....
TOBA BTK trial study publishes one-year results for Tack endovascular system
The TOBA BTK (Tack Optimized Balloon Angioplasty Below the Knee) clinical trial results have recently been published in Catheterization and Cardiovascular Intervention. The multicentre...
FDA approves six-month primary endpoint for Tack endovascular system in below-the-knee disease
The US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint in Intact Vascular’s TOBA II...
Using the Tack endovascular system to treat vessel dissection
At LINC 2017 Vascular News spoke to Peter Schneider (Kaiser Foundation Hospital, Honolulu, Hawaii, USA) about the Tack endovascular system (Intact Vascular), an implant designed to repair...
TOBA II BTK clinical trial commences enrolment with first implant of Tack Endovascular System
Intact Vascular’s TOBA II BTK (Tack optimised balloon angioplasty II below the knee) clinical trial has commenced enrolment, with the first patient treated by Joseph Cardenas at Yuma Regional Hospital and...
Tack endovascular system secures CE mark for repair of dissections following below-the-knee angioplasty
Intact Vascular has attained the CE mark for the Tack endovascular system for the repair of arterial dissections following percutaneous transluminal angioplasty (PTA) below...
Intact Vascular closes on additional funding to advance development of Tack endovascular system
Current Intact Vascular investors—New Enterprise Associates, Quaker Partners and HIG BioHealth Partners—have exercised their right to invest additional capital as part of the company’s...
Physicians and industry alike urged to tackle multifactorial stroke risk following thoracic endovascular procedures
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures,...
Endovascular arteriovenous fistulas “key part of any dialysis programme”
Endovascular arteriovenous fistulas (endoAVF) platforms add additional fistula options for patients and physicians, argues Dheeraj Rajan (University Health Network, University of Toronto, Toronto, Canada,...
Teamwork prescribed to tackle major demographic trends in vascular disease
“Caring for vascular patients is going to take a team,” concluded Marc Bonaca (Boston, USA) at the 2019 Vascular Interventional Advances (VIVA) conference in...
Tack optimised balloon angioplasty safe and effective at six months
The six-month results of the TOBA BTK (Tack optimised balloon angioplasty below the knee) study show that the Tack endovascular system (Intact Vascular) demonstrated...
Intact Vascular secures US$38.9 million financing to accelerate development and approval of the Tack...
The Tack device is an endovascular method for repairing arterial dissections following angioplasty and permits highly targeted repair of diseased arteries, while minimising the metal left behind.
Intact Vascular’s Tack system first-in-man results published
Early experimental and clinical experience with the Tack endovascular system for lower extremity post-angioplasty dissection suggests a safe and feasible alternative treatment.
Risks of endovascular or open repair for aneurysms reviewed
New scoring system provides criteria to quantify perioperative risks in Medicare patients, shows study published in the Journal of Vascular Surgery.
Abbott initiates trial for peripheral stent system
Abbott announces the initiation a clinical trial of the Absolute Pro peripheral self-expanding stent system in patients with iliac artery disease
Gore Flow Reversal System cleared by the FDA
Gore announced at the International Congress on Endovascular Interventions the clearance to market the technology that minimises the risk of emboli reaching the brain during critical stages of carotid artery stenting.
Philips announces positive three-year clinical research results from its TOBA II BTK clinical trial
Royal Philips today announced the latest results from the Tack optimised balloon angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular...
Vascular News’ top 10 most popular stories of June 2021
New data from Philips' TOBA II below-the-knee (BTK) clinical trial, physicians' call for the AMPREDICT decision support tool to be applied in clinical practice,...
Philips announces positive two-year data from TOBA II BTK clinical trial
Royal Philips recently announced positive two-year results from the TOBA (Tack optimised balloon angioplasty) II below-the-knee (BTK) clinical trial.
The data show the Philips...
New tools for CLTI: ISET audience hear what’s on the horizon for these challenging...
“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider (University of California San Francisco, San Francisco,...
New tools for CLTI: ISET audience hear what’s on the horizon for these challenging...
“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider (University of California San Francisco, San Francisco,...
Philips to expand its image-guided therapy portfolio through acquisition of Intact Vascular
Royal Philips today announced that it has signed an agreement to acquire Intact Vascular. According to a press release, Intact Vascular will enhance Philips’...
Intact Vascular announces positive one-year data from TOBA II BTK clinical trial
Intact Vascular announced the positive one-year results from its Tack optimised balloon angioplasty (TOBA) II BTK clinical trial during the 2020 Vascular Interventional Advances (VIVA)...
TOBA III clinical trial results published in the Journal of Vascular Surgery
Intact Vascular has announced the peer-reviewed publication of its Tack optimised balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery.
The multi-centre, single-arm,...
VIVA 2019: TOBA II BTK meets primary safety and efficacy endpoints through six months
It was announced today at the 2019 Vascular Interventional Advances conference (VIVA) (4–7 November, Las Vegas, USA) that, through six months, TOBA II BTK...
Intact Vascular announces positive one-year data from TOBA III clinical trial
Intact Vascular has announced the positive one-year results of its Tack Optimised Balloon Angioplasty (TOBA) III clinical trial, successfully achieving both primary and secondary...
Identifying and repairing dissections that matter
Marianne Brodmann (Graz, Austria) quizzes Michael Lichternberg (Arnsberg, Germany) at LINC 2019 on his choice of tools to identify and repair dissections in both...
TOBA II BTK clinical trial completes enrolment
The Tack Optimised Balloon Angioplasty II below-the-knee (TOBA II BTK) clinical trial has successfully completed enrolment, ahead of schedule. This study, sponsored by Intact...
TOBA II shows repairing dissections after angioplasty “clearly augments” outcomes for PAD patients
Thomas Zeller (Bad Krozingen, Germany) delves into data and design of the TOBA II (Tack Optimized Balloon Angioplasty II) trial with principal investigator William...
TOBA II trial meets primary and secondary endpoints at one-year
The Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has successfully achieved both primary and secondary endpoints. One year results from the TOBA...
Intact Vascular announces presentation of TOBA II pivotal data
Intact Vascular has announced that data from its Tack Optimized Balloon Angioplasty (TOBA) II pivotal study will be presented as a late-breaking clinical trial...
TOBA single-centre trial shows 24-month patency rate of 87.5%
Positive single-centre 24-month results from Intact Vascular’s TOBA (Tack optimised balloon angioplasty) clinical study were presented at the 2017 VEITHsymposium 2017 (14–18 November, New York City, USA) by...
Intact Vascular announces enrolment of first European patient in TOBA II BTK trial
Intact Vascular’s TOBA II BTK (Tack optimized balloon angioplasty II below the knee) clinical trial has commenced enrolment in Europe, with the first patient treated by Marianne Brodmann and Peter Reif...
Intact Vascular appoints Howard Rosen as vice president of marketing and business development
Howard Rosen has joined Intact Vascular’s executive management team as vice president of marketing and business development. In this position, Rosen will lead the...
Intact Vascular completes enrolment in TOBA II clinical trial
Intact Vascular’s TOBA II (Tack optimized balloon angioplasty II) clinical trial has completed enrolment. A total of 210 patients have been enrolled in TOBA II at 33 sites...
North Dallas Research Associates begin enrolling TOBA II BTK patients
North Dallas Research Associates, Dallas, Texas, and its private practice, Cardiac Center of Texas, have announced their participation in the Tack Optimized Balloon Angioplasty II...
FDA approves TOBA II BTK pivotal IDE clinical study
The US Food and Drug Administration (FDA) has granted staged approval for Intact Vascular’s investigational device exemption (IDE) application to begin its TOBA II BTK...
TOBA study results demonstrate 76.4% 12-month primary patency and 89.5% freedom from TLR
The one-year results from Intact Vascular’s Tack Optimized Balloon Angioplasty (TOBA) clinical study have been published in the Journal of Vascular Surgery.
The TOBA study...
Enrolment commences for Intact Vascular’s TOBA III trial
Intact Vascular has announced that its Tack Optimised Balloon Angioplasty III (TOBA III) clinical trial has commenced enrolment, with the first patient treated by...
Positive 12-month TOBA-BTK results presented at SCAI 2016
Positive twelve-month results from Intact Vascular’s Tack optimised balloon angioplasty—below-the-knee (TOBA-BTK) clinical study have been presented at the SCAI 2016 conference (4–7 May, Orlando,...
Intact Vascular presents positive data from TOBA-BTK study at LINC 2016
Positive six-month results from Intact Vascular’s TOBA-BTK (Tack Optimised Balloon Angioplasty—Below-the-Knee) clinical study have been reported at LINC 2016. The data were presented by...
Intact Vascular presents positive data from TOBA-BTK study at LINC 2016
Positive six-month results from Intact Vascular’s TOBA-BTK (Tack Optimised Balloon Angioplasty—Below-the-Knee) clinical study have been reported at LINC 2016. The data were presented by...
Intact Vascular announces conditional FDA approval for TOBA II study and enrolment of first...
The US Food and Drug Administration has granted conditional approval for a US and European Investigational Device Exemption (IDE) clinical trial to investigate the...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
ESVS publishes 2023 guidelines on management of atherosclerotic carotid and vertebral artery disease
The European Society for Vascular Surgery (ESVS) has just released 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease....
Perioperative outcomes of carotid endarterectomy not improved on dual versus single antiplatelet therapy
At the time of carotid endarterectomy (CEA), surgeons should consider single antiplatelet therapy (SAPT) rather than dual antiplatelet therapy (DAPT). This is the conclusion...
New recommendations promote “appropriate and effective” use of social media in medicine
In response to a rapid augmentation of social media use in medicine over the past five years, the Society for Vascular Surgery (SVS) has...
Global vascular community addresses geographic disparity in COVID-19 impact and response
Last week, the Charing Cross (CX) Symposium 2020 would have taken place in London, UK. To mark the occasion virtually, experts from across the...
How artificial intelligence can be used for aneurysm follow-up
In the Aortic session at this year’s Controversies and Updates in Vascular Surgery meeting (CACVS; 23–25 January, Paris, France), Stéphan Haulon and Dominique Fabre...
Training for rupture EVAR response: Formula 1 style
What do Formula 1 cars, space shuttles and airplanes have in common with a ruptured aneurysm? In this article, Colin Bicknell writes about the...
US FDA panel reviews paclitaxel device data: No recommendations issued, as more work is...
The US Food and Drug Administration (FDA) convened this week for a General Issues Panel Meeting on the late mortality safety signal associated with...
STEP seeks to advance patient safety after TEVAR
Stroke is a major concern following TEVAR (thoracic endovascular aortic repair) and Charing Cross delegates heard the results from a collaborative study that pooled...
ESC publishes new guidelines on the diagnosis and treatment of peripheral arterial diseases
European Society of Cardiology (ESC) Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular...
Carotid endarterectomy patients with higher diastolic blood pressure show increased risk of adverse events
Patients with high baseline diastolic blood pressure undergoing carotid endarterectomy are at increased risk of stroke, myocardial infarction, or death within 30 days of...
Silk Road Medical enrols first patient in ROADSTER 2 trial
The first patient has been enrolled in the US ROADSTER 2 post approval study at Greenville Memorial Hospital in Greenville, USA.
ROADSTER 2—a prospective, multicentre...
OCT imaging after carotid artery stenting reveals microdefects related to device design
A study published in the European Journal of Vascular and Endovascular Surgery shows that in the carotid arteries, stent malapposition is more frequent with closed-cell stents while plaque prolapse is more common with open-cell stents.
Intact Vascular announces initiation of the TOBA-BTK study
This multicentre pilot study will gather data supporting the safety and performance of the Tack-It Endovascular System in patients with critical limb ischaemia due to vascular disease below the knee.
Intact Vascular announces completion of enrolment in the TOBA study
The objective of the multicentre study is to gather confirmatory data on the use of the Tack-It Endovascular System in the superficial femoral and popliteal arteries. The principal investigators are Marc Bosiers and Dierk Scheinert.
Piergiorgio Cao
Being the first to use a hybrid endovascular operating room in Italy is one of Piergiorgio Cao’s proudest moments. At the beginning of his...
Overview of vascular imaging modalities
Vascular speciaslists speak about the use of imaging in carotid, venous, thoracic, abdominal aortic aneurysm and lower limb interventions.
One-month data show early safety and effectiveness with the Valiant thoracic stent graft
Initial results from US study demonstrate early safety and effectiveness of the Medtronic device for minimally invasive treatment of thoracic aortic aneurysms.
New exhibitors at CX 31
Every year, new exhibitors see the CX Symposium as an excellent opportunity to showcase their products and services to an internationalaudience of medical professionals.
More questions asked of carotid artery stenting
Key questions regarding the future of carotid stenting.
Delegates prefer surgical stripping
The great varicose vein debate
Charing Cross goes from strength to strength
Last year's Charing Cross International Symposium reached new heights
Coverage for carotid artery stenting in FDA post-approval studies
CMS has issued a final National Coverage Determination
